Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA Defends Adaptive Pathways Against Fresh Attack Following Pilot Report

Executive Summary

The European Medicines Agency has dismissed a call to stop accepting applications for its adaptive pathways program until it has better evidence on how to use real-world data.


Related Content

Failings Of Clinical Trials, Adaptive Pathways Dominate NGO Conference
Adaptive Pathways: Companies Advised To Consider Hurdles As EMA Accepts More Applications
Adaptive licensing: Is the EMA's Rasi heading for a fight with the commission and others in EU?